Roles of elevated 20‑HETE in the breakdown of blood brain barrier and the severity of brain edema in experimental traumatic brain injury

Lu,Liyan; Wang,Mingliang; Yuan,Fang; Wei,Xiaoer; Li,Wenbin

doi:10.3892/mmr.2018.8780

Roles of elevated 20‑HETE in the breakdown of blood brain barrier and the severity of brain edema in experimental traumatic brain injury

Authors:
- Liyan Lu
- Mingliang Wang
- Fang Yuan
- Xiaoer Wei
- Wenbin Li
View Affiliations

Affiliations: Department of Radiology, Nanjing First Hospital, Nanjing Medical University, Nanjing, Jiangsu 210006, P.R. China, Department of Radiology, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai 200233, P.R. China, Department of Neurosurgery, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai 200233, P.R. China
Published online on: March 20, 2018 https://doi.org/10.3892/mmr.2018.8780
Pages: 7339-7345

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Breakdown of the blood brain barrier (BBB) is a secondary injury following traumatic brain injury (TBI) and can lead to the development of brain edema. However, the factors that contribute to the disruption of the BBB and increase the severity of brain edema in TBI remain to be elucidated. 20‑hydroxyeicosatetraenoic acid (20‑HETE) is a metabolite of arachidonic acid. The inhibition of 20‑HETEsynthesis by HET0016 has been suggested as a strategy to decrease brain edema. The present study aimed to investigate whether the elevated production of 20‑HETE in cerebral tissue may contribute to BBB breakdown and increase the severity of brain edema in rats with TBI. BBB permeability was quantified using dynamic contrast‑enhanced magnetic resonance imaging and brain edema was measured according to brain water content. Superoxide production in injured tissue was also assessed. Liquid chromatography‑mass spectrometry was used to evaluate 20‑HETE production in injured tissue. Western blot analysis was used to assess the expression of occludin, zonula occludens (ZO)‑1, matrix metalloproteinase (MMP)‑9, and proteins of the c‑Jun N‑terminal kinase (JNK) pathway. A total of 3, 24 and 72 h following the induction of TBI, 20‑HETE levels, BBB permeability and brain edema were identified to be increased, accompanied by an increase in superoxide production. Conversely, superoxide dismutase levels, in addition to the total antioxidative capability were decreased. In addition, the expression of MMP‑9 and proteins of the JNK pathway was upregulated, whereas the expression of occludin and ZO‑1 was observed to be suppressed. These results suggested that 20‑HETE may aggravate BBB disruption following TBI, via enhancing the expression of MMP‑9 and tight junction proteins. Furthermore, oxidative stress and the JNK signaling pathway may be involved in BBB dysregulation. In conclusion, the results of the present demonstrated that the production of 20‑HETE was increased in cerebral tissue following traumatic injury, thus suggesting that it may contribute to the compromise of BBB integrity and the development of brain edema.

View Figures

View References

1	Birnie M, Morrison R, Camara R and Strauss KI: Temporal changes of cytochrome P450 (Cyp) and eicosanoid-related gene expression in the rat brain after traumatic brain injury. BMC Genomics. 14:3032013. View Article : Google Scholar : PubMed/NCBI
2	Yang S, Ma Y, Liu Y, Que H, Zhu C and Liu S: Arachidonic acid: A bridge between traumatic brain injury and fracture healing. J Neurotrauma. 29:2696–2705. 2012. View Article : Google Scholar : PubMed/NCBI
3	Johnson AL, Edson KZ, Totah RA and Rettie AE: Cytochrome P450 ω-hydroxylases in inflammation and cancer. Adv Pharmacol. 74:223–262. 2015. View Article : Google Scholar : PubMed/NCBI
4	Harder DR, Gebremedhin D, Narayanan J, Jefcoat C, Falck JR, Campbell WB and Roman R: Formation and action of a P-450 4A metabolite of arachidonic acid in cat cerebral microvessels. Am J Physiol. 266:H2098–H2107. 1994.PubMed/NCBI
5	Zhu J, Wang B, Lee JH, Armstrong JS, Kulikowicz E, Bhalala US, Martin LJ, Koehler RC and Yang ZJ: Additive neuroprotection of a 20-HETE inhibitor with delayed therapeutic hypothermia after hypoxia-ischemia in neonatal piglets. Dev Neurosci. 37:376–389. 2015. View Article : Google Scholar : PubMed/NCBI
6	Garcia V, Cheng J, Weidenhammer A, Ding Y, Wu CC, Zhang F, Gotlinger K, Falck JR and Schwartzman ML: Androgen-induced hypertension in angiotensinogen deficient mice: Role of 20-HETE and EETS. Prostaglandins Other Lipid Mediat. 116-117:124–130. 2015. View Article : Google Scholar : PubMed/NCBI
7	Toth P, Csiszar A, Sosnowska D, Tucsek Z, Cseplo P, Springo Z, Tarantini S, Sonntag WE, Ungvari Z and Koller A: Treatment with the cytochrome P450 ω-hydroxylase inhibitor HET0016 attenuates cerebrovascular inflammation, oxidative stress and improves vasomotor function in spontaneously hypertensive rats. Br J Pharmacol. 168:1878–1888. 2013. View Article : Google Scholar : PubMed/NCBI
8	Wei XE, Zhang YZ, Li YH, Li MH and Li WB: Dynamics of rabbit brain edema in focal lesion and perilesion area after traumatic brain injury: A MRI study. J Neurotrauma. 29:2413–2420. 2012. View Article : Google Scholar : PubMed/NCBI
9	Cai H, Mu Z, Jiang Z, Wang Y, Yang GY and Zhang Z: Hypoxia-controlled matrix metalloproteinase-9 hyperexpression promotes behavioral recovery after ischemia. Neurosci Bull. 31:550–560. 2015. View Article : Google Scholar : PubMed/NCBI
10	Xu FF, Sun S, Ho AS, Lee D, Kiang KM, Zhang XQ, Wang AM, Wu EX, Lui WM, Liu BY and Leung GK: Effects of progesterone vs. dexamethasone on brain oedema and inflammatory responses following experimental brain resection. Brain Inj. 28:1594–1601. 2014. View Article : Google Scholar : PubMed/NCBI
11	Kim JY, Ko AR, Hyun HW and Kang TC: ETB receptor-mediated MMP-9 activation induces vasogenic edema via ZO-1 protein degradation following status epilepticus. Neuroscience. 304:355–367. 2015. View Article : Google Scholar : PubMed/NCBI
12	Wu G, Wu J, Jiao Y, Wang L, Wang F and Zhang Y: Rosiglitazone infusion therapy following minimally invasive surgery for intracerebral hemorrhage evacuation decreases matrix metalloproteinase-9 and blood-brain barrier disruption in rabbits. BMC Neurol. 15:372015. View Article : Google Scholar : PubMed/NCBI
13	Wang GY, Wang N and Liao HN: Effects of muscone on the expression of P-gp, MMP-9 on blood-brain barrier model in vitro. Cell Mol Neurobiol. 35:1105–1115. 2015. View Article : Google Scholar : PubMed/NCBI
14	Liu Y, Wang D, Wang H, Qu Y, Xiao X and Zhu Y: The protective effect of HET0016 on brain edema and blood-brain barrier dysfunction after cerebral ischemia/reperfusion. Brain Res. 1544:45–53. 2014. View Article : Google Scholar : PubMed/NCBI
15	Urrutia A, Rubio-Araiz A, Gutierrez-Lopez MD, ElAli A, Hermann DM, O'Shea E and Colado MI: A study on the effect of JNK inhibitor, SP600125, on the disruption of blood-brain barrier induced by methamphetamine. Neurobiol Dis. 50:49–58. 2013. View Article : Google Scholar : PubMed/NCBI
16	Jungner M, Siemund R, Venturoli D, Reinstrup P, Schalén W and Bentzer P: Blood-brain barrier permeability following traumatic brain injury. Minerva Anestesiol. 82:525–533. 2016.PubMed/NCBI
17	Hanrahan F and Campbell M: Frontiers in neuroscience neuroinflammationTranslational research in traumatic brain injury. Laskowitz D and Grant G: CRC Press/Taylor and Francis Group (c) 2016 by Taylor & Francis Group LLC; Boca Raton (FL): 2016
18	Gasche Y, Copin JC, Sugawara T, Fujimura M and Chan PH: Matrix metalloproteinase inhibition prevents oxidative stress-associated blood-brain barrier disruption after transient focal cerebral ischemia. J Cereb Blood Flow Metab. 21:1393–1400. 2001. View Article : Google Scholar : PubMed/NCBI
19	Lapchak PA, Chapman DF and Zivin JA: Metalloproteinase inhibition reduces thrombolytic (tissue plasminogen activator)-induced hemorrhage after thromboembolic stroke. Stroke. 31:3034–3040. 2000. View Article : Google Scholar : PubMed/NCBI
20	Gu JH, Ge JB, Li M, Xu HD, Wu F and Qin ZH: Poloxamer 188 protects neurons against ischemia/reperfusion injury through preserving integrity of cell membranes and blood brain barrier. PLoS One. 8:e616412013. View Article : Google Scholar : PubMed/NCBI
21	Wang ZG, Cheng Y, Yu XC, Ye LB, Xia QH, Johnson NR, Wei X, Chen DQ, Cao G, Fu XB, et al: bFGF protects against blood-brain barrier damage through junction protein regulation via PI3K-Akt-Rac1 pathway following traumatic brain injury. Mol Neurobiol. 53:7298–7311. 2015. View Article : Google Scholar : PubMed/NCBI
22	Liu Y, Wang H and Zhu Y, Chen L, Qu Y and Zhu Y: The protective effect of nordihydroguaiaretic acid on cerebral ischemia/reperfusion injury is mediated by the JNK pathway. Brain Res. 1445:73–81. 2012. View Article : Google Scholar : PubMed/NCBI
23	Mehta SL, Manhas N and Raghubir R: Molecular targets in cerebral ischemia for developing novel therapeutics. Brain Res Rev. 54:34–66. 2007. View Article : Google Scholar : PubMed/NCBI
24	Yu W, Chen L, Yang YQ, Falck JR, Guo AM, Li Y and Yang J: Cytochrome P450 ω-hydroxylase promotes angiogenesis and metastasis by upregulation of VEGF and MMP-9 in non-small cell lung cancer. Cancer Chemother Pharmacol. 68:619–629. 2011. View Article : Google Scholar : PubMed/NCBI
25	Fordsmann JC, Ko RW, Choi HB, Thomsen K, Witgen BM, Mathiesen C, Lønstrup M, Piilgaard H, MacVicar BA and Lauritzen M: Increased 20-HETE synthesis explains reduced cerebral blood flow but not impaired neurovascular coupling after cortical spreading depression in rat cerebral cortex. J Neurosci. 33:2562–2570. 2013. View Article : Google Scholar : PubMed/NCBI